Share this article
The subsidiary provides CDMO services, utilizing 57,000 sq. ft. of laboratory space and cutting-edge process chemistry technology in Princeton South, New Jersey and Richmond, Virginia.
KOLKATA, India, Feb. 4, 2021 /PRNewswire/ --
TCG GreenChem provides high-end, integrated CMC services covering development to cGMP clinical trial supplies
TCG GreenChem will accelerate the transition of drug candidates through the development pipeline efficiently and economically utilizing innovative catalysis and continuous flow chemistry technologies
TCG GreenChem will be seamlessly integrated with TCG Lifesciences' India operations to serve its global customers across the full range of discovery, development, and commercial applications
TCG Greenchem
TCG Lifesciences Pvt. Ltd., a company controlled by New York-based The Chatterjee Group ("TCG"), has announced today the expansion of its operations in the USA with the establishment of TCG GreenChem Inc., a subsidiary of TCG Lifesciences Pvt. Ltd, to provide CDMO services to global clients.TCG GreenChem, Inc., offers seamless CMC development services including process research & development and delivery of cGMP APIs. It aims at utilizing its deep expertise in areas of automated catalysis/reaction screening, reaction optimization, and continuous chemistry to support the needs of the big pharma and biotech industry. It has a robust pipeline of projects with its customers to manage their entire portfolios, offering integrated CMC and supply of APIs from early clinical trials to commercialization.